|
1. 黃金池. 龍葵. 農業週刊 1985;11:26-7. 2. 楊再義. 台灣植物名彙. 天然書社有限公司 1982:1138. 3. 劉春安,彭明. 抗癌中草藥大辭典. 湖北科學技術出版社 1994;3:294-7. 4. Saijo R, Murakami K, Nohara T, Tomimatsu T, Sato A, Matsuoka K. [Studies on the constituents of Solanum plants. II. On the constituents of the immature berries of Solanum nigrum L. (author''s transl)]. Yakugaku Zasshi 1982;102(3):300-5. 5. Sultana S, Perwaiz S, Iqbal M, Athar M. Crude extracts of hepatoprotective plants, Solanum nigrum and Cichorium intybus inhibit free radical-mediated DNA damage. J Ethnopharmacol 1995;45(3):189-92. 6. Son YO, Kim J, Lim JC, Chung Y, Chung GH, Lee JC. Ripe fruit of Solanum nigrum L. inhibits cell growth and induces apoptosis in MCF-7 cells. Food Chem Toxicol 2003;41(10):1421-8. 7. Lee SJ, Ko JH, Lim K, Lim KT. 150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse. Pharmacol Res 2005;51(5):399-408. 8. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 1989;341(6238):162-4. 9. Virella G, Lopes-Virella MF. Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis 2008. 10. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8(11):1211-7. 11. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110(2):227-39. 12. Lusis AJ. Atherosclerosis. Nature 2000;407(6801):233-41. 13. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272(34):20963-6. 14. Harats D, Shaish A, George J, et al. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2000;20(9):2100-5. 15. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998;141(1):1-15. 16. Napoli C, D''Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997;100(11):2680-90. 17. Navab M, Berliner JA, Watson AD, et al. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996;16(7):831-42. 18. Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res 1999;41(2):361-8. 19. Colles SM, Irwin KC, Chisolm GM. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol. J Lipid Res 1996;37(9):2018-28. 20. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320(14):915-24. 21. Halka AT, Turner NJ, Carter A, et al. The effects of stretch on vascular smooth muscle cell phenotype in vitro. Cardiovasc Pathol 2008;17(2):98-102. 22. Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2(2):275-81. 23. Sugden PH, Clerk A. Activation of the small GTP-binding protein Ras in the heart by hypertrophic agonists. Trends Cardiovasc Med 2000;10(1):1-8. 24. Sun Y, Weber KT. RAS and connective tissue in the heart. Int J Biochem Cell Biol 2003;35(6):919-31. 25. Nowak JM, Grzanka A, Zuryn A, Stepien A. [The Rho protein family and its role in the cellular cytoskeleton]. Postepy Hig Med Dosw (Online) 2008;62:110-7. 26. Kost B. Spatial control of Rho (Rac-Rop) signaling in tip-growing plant cells. Trends Cell Biol 2008;18(3):119-27. 27. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002;2(2):133-42. 28. Bokoch GM, Der CJ. Emerging concepts in the Ras superfamily of GTP-binding proteins. FASEB J 1993;7(9):750-9. 29. Downward J. The ras superfamily of small GTP-binding proteins. Trends Biochem Sci 1990;15(12):469-72. 30. Hall C, Sin WC, Teo M, et al. Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes. Mol Cell Biol 1993;13(8):4986-98. 31. Chen CC, Hsu JD, Wang SF, et al. Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits. J Agric Food Chem 2003;51(18):5472-7. 32. Saxty BA, Yadollahi-Farsani M, Kefalas P, Paul S, MacDermot J. Inhibition of chemotaxis in A7r5 rat smooth muscle cells by a novel panel of inhibitors. Br J Pharmacol 1998;125(1):152-8. 33. Galkina E, Ley K. Leukocyte influx in atherosclerosis. Curr Drug Targets 2007;8(12):1239-48. 34. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 2005;96(3):327-36. 35. Moiseeva EP. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 2001;52(3):372-86. 36. Huang HC, Jan TR, Yeh SF. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 1992;221(2-3):381-4. 37. Huang HC, Wang HR, Hsieh LM. Antiproliferative effect of baicalein, a flavonoid from a Chinese herb, on vascular smooth muscle cell. Eur J Pharmacol 1994;251(1):91-3. 38. Chen HW, Huang HC. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol 1998;124(6):1029-40. 39. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11(1):2-14. 40. Barter P, Kastelein J, Nunn A, Hobbs R. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 2003;168(2):195-211. 41. Kato M, Inazu T, Kawai Y, et al. Amphiregulin is a potent mitogen for the vascular smooth muscle cell line, A7r5. Biochem Biophys Res Commun 2003;301(4):1109-15. 42. Zhang J, Fu M, Zhu X, et al. Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells. J Biol Chem 2002;277(13):11505-12. 43. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983;32(7):1141-8. 44. Takahama U. Inhibition of lipoxygenase dependent lipid peroxidation by quercetin: Mechanism of antioxidative function. Phytochemistry. Phytochemistry 1985; 24: 1443-6. 45. Katan MB. Flavonoids and heart disease. Am J Clin Nutr 1997;65(5):1542-3. 46. Raju K, Anbuganapathi G, Gokulakrishnan V, Rajkapoor B, Jayakar B, Manian S. Effect of dried fruits of Solanum nigrum LINN against CCl4-induced hepatic damage in rats. Biol Pharm Bull 2003;26(11):1618-9. 47. Lin HM, Tseng HC, Wang CJ, et al. Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. J Agric Food Chem 2007;55(9):3620-8. 48. Li PG, Xu JW, Ikeda K, et al. Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats. Hypertens Res 2005;28(4):369-77.
|